INTRODUCTION
============

The molecular sequelae of events leading to the adverse and sometimes lethal outcome of sepsis have not been fully elucidated \[[@B1]\]. Cytokines are undoubtedly involved in these processes \[[@B2], [@B3], [@B4]\], with the proinflammatory cytokines tumor necrosis factor-*α* (TNF-*α*), interleukin-1, macrophage migration inhibitory factor (MIF), and others playing a pivotal role \[[@B4], [@B5]\]. Cytokines have been considered promising clinical targets in the treatment of shock, but, to date, anticytokine-based therapeutic strategies such as the use of anti-TNF antibodies, soluble TNF receptors, or interleukin-1 receptor antagonists have failed to show a clear clinical benefit \[[@B6]\].

Experimental and clinical studies have demonstrated that exposure to endotoxin (lipopolysaccharide (LPS)) results in the release of various inflammatory mediators. TNF-*α* is a proinflammatory cytokine greatly involved in the pathophysiological changes associated with acute and chronic inflammatory conditions, including septic shock, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, and the respiratory distress syndrome \[[@B7], [@B8]\].

In addition some antioxidants and reactive oxygen species (ROS) scavengers exert a protective action against endotoxic shock in rodents by inhibiting TNF-*α* \[[@B9]\].

Ozone/oxygen mixture has a strong microbiocidal activity in vitro \[[@B6]\] comparable to the potent bactericidal activity of NO \[[@B10]\], and might therefore act as a regulator or modulator of many inflammatory processes in vivo. Ozone/oxygen mixture exhibits various effects on the immune system \[[@B11]\], such as the modulation of phagocytic activity of peritoneal \[[@B12]\], and alveolar \[[@B13]\], macrophages, which generates the first line of defense against bacteria and/or its toxins. Therefore, it can be hypothesized that ozone/oxygen mixture enhances the production/release of proinflammatory cytokine in different abdominal organs (eg, spleen, liver) and may be able to influence the outcome of a severe infection.

Repeated rectal administrations of ozone have induced a sort of cross-tolerance to free radicals released after hepatic and renal ischemia-reperfusion \[[@B14], [@B15], [@B16], [@B17]\]. Also it has been demonstrated that low doses of ozone increased antioxidant endogenous systems involving glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT), preparing the host to face physiopathological conditions mediated by ROS \[[@B14], [@B15], [@B16], [@B17], [@B18]\], and demonstrating that ozone, probably by means of an oxidative preconditioning mechanism, similarly to ischemic preconditioning, protected these organs from the damage produced by ROS, which induced improvement of antioxidant-prooxidant balance and the concomitant preservation of cell redox state \[[@B19]\]. Ozone therapy has also been proved efficient in the treatment of many diseases and beneficial effects have been observed with it \[[@B17], [@B18], [@B20], [@B21]\]. Ozone oxidative preconditioning (OOP) also showed a beneficial effect in lethal polymicrobial sepsis in rats because it increased animal survival and protected them from death \[[@B22], [@B23]\].

Recently it has also been demonstrated that OOP administered into the abdomen of rats leads to altered sleeping time and to changes in the loss of reflexes \[[@B24]\]. These alterations in the strength of anesthesia are paralleled by a modulation of proinflammatory cytokines levels beyond those seen for a given anesthetic drug alone \[[@B25]\].

Taking into account the former results, we decided to analyze the effect of OOP on serum TNF-*α* levels and as a modulator of oxidative stress on hepatic tissue in endotoxic shock model mice treated with LPS.

MATERIALS AND METHODS
=====================

Animals and treatments
----------------------

Adult male BALB/c mice obtained from the National Center for Laboratory Animal Production (Havana, Cuba) weighing 18−20 g were used in this study (*n* = 35). Mice were housed in plexiglass cages, maintained in an air-filtered and temperature-conditioned (20−22^°^C) room with a relative humidity of 50%--52% and under an artificial light/dark cycle of 12 hours.

Animals were fed with standard laboratory chow and water ad libitum. LPS (Sigma, St. Louis, Mo; Serotype 055:B~5~ from *Escherichia coli*) was given intraperitoneally (IP) at 0.1 mg/kg, dissolved in sterile pyrogen-free saline solution.

Ozone (O~3~) was generated by OZOMED 01 equipment manufactured by the Ozone Research Center (Cuba). Ozone obtained from medicinal grade oxygen was used immediately. The ozone concentration was measured by using a UV spectrophotometer at 254 nm.

Experimental design
-------------------

Ozone/oxygen mixture was administered IP at doses of 0.2, 0.4, and 1.2 mg/kg. The volume of gaseous mixture administered to each animal was approximately 1 mL. Oxidative preconditioning was performed with five applications (one daily) of the ozone/oxygen mixture. LPS was injected twenty-four hours after the last ozone/oxygen administration.

A control group receiving LPS and two other groups receiving saline or ozone/oxygen mixture alone were also included. Dexamethasone (30 mg/kg) used as a reference drug was administered IP in saline solution 30 minutes before LPS. The mice were bled from the retroorbital plexus under light anesthesia and serum TNF-*α* was measured 1 hour after administration of LPS.

Effect of OOP on kinetics of TNF-*α* release in serum after LPS injection
-------------------------------------------------------------------------

Another experiment was performed in order to study whether OOP has some influence on the normal kinetic TNF-*α* release after LPS injection.

Ozone/oxygen mixture was administered as described before but just using the highest dose (1.2 mg/kg) IP. LPS was injected twenty-four hours after the last ozone/oxygen mixture administration.

A control group receiving LPS and two other groups receiving saline or ozone/oxygen mixture alone were also included. Dexamethasone (30 mg/kg) used as a reference drug was administered IP in saline solution 30 minutes before LPS. The mice were bled from the retroorbital plexus under light anesthesia and serum TNF-*α* was measured 0.5, 1, 2, and 3 hours after administration of LPS. Biochemical parameters such as thiobarbituric acid reactive substances (TBARS), enzymatic activity of CAT, glutathione peroxidase (GSH-Px), and glutathione-S transferase (GST) were measured in hepatic tissue.

The experiments were conducted in accordance with the ethical guidelines for investigations in laboratory animals and were approved by the Ethical Committee for Animal Experimentation of the National Center for Scientific Research (CNIC), Havana, Cuba.

TNF-*α* assay
-------------

TNF-*α* was measured by cytotoxicity on L929 cells \[[@B17]\]. TNF levels were determined using recombinant human TNF-*α* (BASF/Knoll, Ludwigshafen, Germany; specific activity 10^7^ U/mg) and expressed in pg/mL. Five mice per group were used and results were compared by Student *t* test. Results are expressed as an inhibition percentage of TNF-*α* production. All experiments were repeated at least twice.

Biochemical assays
------------------

Liver homogenates were obtained using a tissue homogenator Ultraturrax T25 Polytron at 4^°^C. The homogenates (10% w/v) for GSH-Px and GST were prepared by using KCl 1.15% in aqueous solution. Liver homogenates for CAT enzymatic assay were obtained with a 50 mM phosphate buffer (pH 7) containing 1% Triton X-100 (1 : 9 w/v) (buffer 2).

The homogenates were centrifuged at 600 g for 60  minutes at 4^°^C and the supernatants were taken for biochemical determinations.

Determination of TBARS
----------------------

Thiobarbituric acid reactive substances (TBARS) were determined spectrophotometrically by a modified version of the method of Botsoglou et al \[[@B26]\]. The homogenate for TBARS was prepared by transferring 2 g of the sample to a tube, and volumes of 5% aqueous trichloroacetic acid (TCA) (8 mL) and 0.8% butylated hydroxy toluene (BHT) in hexane (5 mL) were immediately added. The content of the tube was ultraturraxed for 30 seconds at high speed and centrifuged for 3 minutes at 3000 g, and the top hexane layer was discarded. The bottom aqueous layer was made to 10 mL volume with 5% TCA, and a 2.5 mL aliquot was pipetted into a screw-capped tube to which a volume (1.5 mL) of 0.8% aqueous TBA, besides 1.5 mL of TCA 5%, 0.2 mL of sodium dodecyl sulphate (SDS) 8.1%, and 0.6 mL of distilled water, was also added. Following incubation for 30 minutes at 70^°^C, the tube was cooled under tap water and 5 mL of butanol-pyridine (15 : 1) mixture was added. The content of the tube was strongly vortexed and centrifuged for 15 minutes at 3000 g at room temperature. The optical density of the top layer was measured at 532 nm using 1,1,3,3-tetraethoxypropane as a standard.

Determination of GST
--------------------

The GST activity was determined using GSH and 1-chloro-2,4-dinitrobenzene (CDNB) as the second substrate, according to the method of Habig et al \[[@B27]\]. An aliquot of 0.015 mL of the supernatant was added to the reaction mixture containing 0.2380 mL of 0.1 M potassium phosphate buffer (pH 6.5) and 0.1 mL of CDNB 1 mM in ethanolic solution. Afterward, 0.5 mL of GSH 10 mM was added to the reaction mixture and optical density was measured during 5 minutes in the spectrophotometer. A molar extinction coefficient of 9.6 × 10^3^ M cm^−1^ was used to determine the activity of GST.

Determination of CAT activity
-----------------------------

CAT was determined according to the method of Rice-Evans and Diplock \[[@B28]\]. Liver homogenate was diluted with buffer 2, as described before, to obtain an adequate dilution of the enzyme. Then, 2 mL of the enzyme dilution were added to the cuvette and mixed with 1 mL of 30 mM H~2~O~2~, and then the absorbance was measured at 240 nm, for 30 seconds in the spectrophotometer. Initial absorbance of the reaction mixture must be around 0.5. The enzyme activity is expressed as the first order constant that describes the decomposition of H~2~O~2~ at room temperature.

Determination of GSH-Px activity
--------------------------------

GSH-Px was measured using a modified version of the method of Faraji et al \[[@B29]\]. All reaction mixtures were dissolved in 20 mM sodium phosphate buffer containing 6 mM EDTA (pH 7.0). The reaction mixture consisted of 98.8 *μ*L of phosphate buffer, 700 *μ*L of 2.86 mM GSH, 100 *μ*L of 1 mM sodium azide, 100 *μ*L of 1 mM NADPH, and 4.2 *μ*L of GSH reductase (0.5 units). Then, 10 *μ*L of the tissue homogenate supernatant was added to the reaction mixture and incubated at room temperature for 10--15 minutes. Afterward, 10 *μ*L of 30 mM t-butyl hydroperoxide (dissolved in bidistilled water) was added to the reaction mixture and measured at 340 nm for 7 minutes in the spectrophotometer. A molar extinction coefficient of 6.22 × 10^3^ M cm^−1^ was used to determine the activity of GSH-Px. The enzyme activity is expressed in international units of enzymatic activity/mg of protein. International units are expressed in *μ* mol of hydroperoxides transformed /min/mL of enzyme.

Protein assay
-------------

Protein concentrations were determined by the method of Lowry et al \[[@B30]\] using bovine serum albumin as a standard.

Statistical analysis
--------------------

Data were expressed in means ± SEM and analyzed statistically using one-way student *t* test, whereas Kruskall-Wallis test followed by Mann-Whitney test was applied for the rest of the markers. The 0.05 level of probability was used as statistical significance.

RESULTS
=======

Effect of ozone oxidative preconditioning on TNF-*α* levels in mouse serum
--------------------------------------------------------------------------

One hour after LPS injection there was a significant increase in TNF-*α* levels ([Table 1](#T1){ref-type="table"}). OOP reduced TNF-*α* release provoked by LPS in a dose-dependent manner. This reduction was statistically significant in all the administered doses. Ozone/oxygen IP applications at 0.4 and 1.2 mg/kg produced an almost total inhibition of TNF-*α* release. The effects of ozone/oxygen IP applications at 0.4 and 1.2 mg/kg were quite similar to the inhibition achieved by dexamethasone, a well-known inhibitor of TNF-*α* release. When ozone/oxygen mixture (1.2 mg/kg) was administered alone, no effect on TNF-*α* induction was observed ([Table 1](#T1){ref-type="table"}).

Effect of OOP on kinetics of TNF-*α* release in serum after LPS injection
-------------------------------------------------------------------------

A preliminary kinetics study of TNF-*α* production in serum 0.5, 1, 2, and 3 hours after LPS injection showed that the maximal level of TNF-*α* in serum occurred 1 hour after LPS injection for all groups studied while after 2 and 3 hours the levels of TNF-*α* were lower than 10  pg/mL, and were considered as zero. It has demonstrated that OOP did not affect the normal kinetics of TNF-*α* release in serum from macrophages in the period after LPS injection in mice ([Figure 1](#F1){ref-type="fig"}).

Biochemical parameters
----------------------

In spite of the significant increase in TNF-*α* level 1 hour after the LPS injection, there was no difference in biochemical markers measured 0.5, 1, 2, and 3 hours after LPS (data not shown). [Table 1](#T1){ref-type="table"} shows the changes in TBARS, CAT, GSH-Px, and GST in the hepatic tissue of mice. In LPS-treated mice the enzymatic activity of CAT was slightly increased, whereas a significant decrease was observed in GSH-Px and GST. TBARS were augmented to 238% in comparison with nontreated controls.

Dexamethasone was applied 30 minutes before LPS as a reference anti-inflammatory drug, showing no significant changes in CAT activity in these conditions. On the contrary, activity of GSH-Px was significantly increased compared with nontreated and LPS-treated mice. Dexamethasone showed 40% of enhancement of GSH-Px activity whereas GST activity was unchanged. This drug also reduced TBARS to values even lower compared with nontreated mice, showing a diminution of 89.9% with respect to LPS-treated mice.

Ozone oxidative preconditioning before LPS 0.1 mg/kg has not shown any significant change in CAT activity, whereas GSH-Px activity was increased to 78% compared with nontreated control. Also we have observed a significant increase in GST activity to 56.9% and TBARS levels were diminished to 60% as compared to nontreated control ([Table 2](#T2){ref-type="table"}).

DISCUSSION
==========

Oxidative preconditioning \[[@B14]\] is analogous to other phenomena such as ischemic preconditioning \[[@B31]\], thermal preconditioning \[[@B32]\], and chemical preconditioning \[[@B33]\]. All of these processes have in common that a repeated and controlled stress is able to provide protection against a prolonged and severe stress. Intrarectal ozone has conferred protection against the hepatic ischemia-reperfusion injury by the adenosine accumulation and by blocking the xanthine/xanthine oxidase pathway, decreasing ROS generation after reperfusion \[[@B16]\]. Recently, it has been demonstrated that intrarectal ozone/oxygen mixture reduced ROS by the stimulation and/or preservation of the endogenous antioxidant systems in experimental models of liver and renal ischemia-reperfusion, respectively \[[@B14], [@B15], [@B16], [@B17], [@B33], [@B34], [@B35], [@B36]\]. Also, it has been shown that there is an increase in the activity of antioxidant enzymes such as SOD and GSH-Px and a decrease of malondialdehyde after ozone preconditioning in cardiopathy patients \[[@B18]\].

We observed a significant inhibitory effect of serum TNF-*α* release on mice pretreated with ozone/oxygen mixture by IP route before induction of endotoxic shock by LPS.

Intraperitoneal injections of ozone/oxygen mixture might produce a direct effect on peritoneal macrophages, modulating their phagocytic activity \[[@B12]\], hypothesizing that this treatment might modify the production/release of proinflammatory cytokines in different abdominal organs as it occurs in the ozonized blood in vitro which causes a release of different cytokines such as TNF-*α*, GM-CSF, IL-2, or IFN-*α* \[[@B35], [@B36], [@B37]\].

To our knowledge, this is the first report on the inhibitory effect of OOP on TNF-*α* release in serum in an experimental model of endotoxic shock in mice.

In our opinion, the inhibitory effects of ozone/oxygen mixture on TNF-*α* levels in the serum of mice treated with endotoxin are a consequence of the stimulation of the antioxidant defenses induced by ozone therapy. This point of view is scientifically supported by the fact that ROS are strongly involved in the induction and development of the inflammatory process and in the pathogenesis of endotoxic shock \[[@B38]\].

On the other hand, various antioxidants, with ROS scavenging properties, protected mice against endotoxin-mediated organ injury and reduced TNF-*α* levels in blood serum \[[@B38]\]. It has been ascribed by some authors to the effect of antioxidant agent on the inhibition of the nuclear transcription factor kappa B (NF-*κ*B) activation. NF-*κ*B is activated by ROS, with the subsequent induction of various cytokines and enzymes such as TNF-*α*, which are involved in the induction and development of endotoxic shock \[[@B37]\].

In the late 1980s and early 1990s, observations led to the conclusion that TNF was a prerequisite for the induction of many other inflammatory cytokines. Injection of LPS into experimental animals \[[@B39]\] or into human volunteers \[[@B40]\] led to the appearance of TNF in the bloodstream before any other cytokine. The maximal plasma levels for TNF are 1.5 hours after injection \[[@B41], [@B42]\]. These results are in agreement with the obtained by us, in which the maximal point of TNF-*α* level in serum was found after 1 hour.

Endotoxaemia, sepsis, and septic shock are associated with the generation of ROS. The overproduction of ROS in shock leads to a considerable oxidant stress as indicated by lipid peroxidation, high blood levels of malondialdehyde and conjugated dienes, as well as the consumption of the endogenous antioxidant vitamins C and E. Some authors reported a decline in the expression of copper/zinc SOD in rats with endotoxic shock using LPS dose of 10 mg/kg \[[@B43]\]. Moreover, mice injected with LPS 100 mg/kg showed a significant increase of ROS production, TNF-*α*, and IL-1*β* release by peritoneal leukocytes, generating an oxidative stress \[[@B44]\].

In this work we test some markers of oxidative stress in hepatic tissue of mice injected with LPS 0.1 mg/kg. We observed that LPS at 0.1 mg/kg provoked a slight increase in CAT activity, as well as a decrease in GSH-Px and a significant increase in malondialdehyde levels, measured as TBARS. The slight increase in CAT activity in LPS-injected mice might be related with the generation of ROS such as hydrogen peroxide and peroxynitrite associated with endotoxaemia.

Ozone oxidative preconditioning appears to restore the oxidant balance, minimizing tissue injury caused by endotoxaemia. Selenium-dependent GSH-Px and GST were found to be biomarkers of endovenous ozone therapy \[[@B45]\]. Both enzymes are involved in detoxification of lipoperoxides, although GST is a toxicologically multifunctional enzyme that catalyzes the conjugation of xenobiotics with GSH, among others. Both GSH-Px and GST activities were enhanced by ozone IP applications in this experiment.

Considering either the effects of diminution of serum TNF-*α* release, the enhancement of antioxidant enzymes, or the decrease in malondialdehyde levels in hepatic tissue, ozone/oxygen IP applications exert beneficial effects in this model of shock, avoiding the establishment of a chronic inflammatory response and an oxidative stress. In our opinion, the inhibitory effects of the ozone/oxygen mixture in TNF-*α* levels in serum of mice injected with endotoxin and the stimulation of the antioxidant activity on hepatic tissue might be ascribed to the inhibition of the activation of the NF-*κ*B which are activated by ROS with the subsequent induction and expression of various cytokines and enzymes such as TNF-*α* and GSH-Px, respectively, which are involved in the induction and development of endotoxic shock.

Taking into account our results and the former findings of other authors described above it is conceivable that, as occurs with other antioxidants and ROS scavengers, OOP might exert its effects on endotoxic shock by inhibition of NF-*κ*B activation. This may explain its inhibitory effects on TNF-*α*. However, further studies will be needed to elucidate the mechanisms underlying the beneficial effect of OOP.
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![Time curve of serum TNF-*α* levels in mice after LPS injection. Data less than 10 pg/mL were considered as 0.](MI2005-16.001){#F1}

###### 

Effects of ozone oxidative preconditioning on serum TNF-*α* levels in mice treated with LPS.

  -------------------------------- ----------------------------------------- ------
  Treatment (mg/kg)                TNF-*α* (pg/mL)                           
  Mean ± SEM                       Inhibition (%)                            
                                                                             
  Saline                           0                                         0
  Ozone /oxygen (1.2), IP          0                                         0
  LPS (0.1 mg/kg)                  2200 ± 780                                ---
  Ozone /oxygen IP (0.2) + LPS     485 ± 120[∗](#TF1){ref-type="table-fn"}   78
  Ozone /oxygen IP (0.4) + LPS     33 ± 17[∗∗](#TF2){ref-type="table-fn"}    98.5
  Ozone /oxygen IP (1.2) + LPS     30.6 ± 5[∗∗](#TF2){ref-type="table-fn"}   99
  Dexamethasone (30 mg/kg) + LPS   29 ± 10[∗∗](#TF2){ref-type="table-fn"}    98.7
  -------------------------------- ----------------------------------------- ------

^∗^*P* \< .05.

^∗∗^*P* \< .01 versus respective control (LPS) by Student *t* test (*n* = 5). The animals were pretreated with five IP applications of ozone (one daily) at 0.2, 0.4, and 1.2 mg/kg twenty four hours after the last ozone administration LPS was given (0.1 mg/kg) and 1 hour later blood samples were taken to measure TNF-*α* levels in serum. Dexamethasone (30 mg/kg IP, 30 minutes before LPS) was used as a control drug.

###### 

Biochemical determinations in experimental groups.

  ------------------------ ----------------- ----------------------------- --------------------------- ------------------------
  Groups                   TBARS (nmol/mg    CAT (k~15~/g of wet tissue)   GSH-Px (IU/mg of protein)   GST (IU/mg of protein)
  of protein)                                                                                          
                                                                                                       
  Nontreated control       0.97 ± 0.066^a^   30.48 ± 0.316^a^              7136.3 ± 786.49^a^          1592.6 ± 195.03^a^
  LPS (0.1 mg/kg)          3.28 ± 0.582^b^   34.20 ± 2.410^b^              5764.6 ± 1012.73^b^         1273.4 ± 250.53^b^
  DEX (30 mg/kg) + LPS     0.33 ± 0.041^c^   30.33 ± 5.200^a^              10 006.2 ± 1457.82^c^       1602.8 ± 310.01^a^
  O~3~ (1.2 mg/kg) + LPS   0.39 ± 0.075^c^   30.68 ± 1.140^a^              12 745.37 ± 2653.08^c^      2498.3 ± 225.77^c^
  ------------------------ ----------------- ----------------------------- --------------------------- ------------------------

Data are presented as mean ± standard error of the mean for ten animals per group.

Different letters mean significant differences between groups (*P* \< .05). CAT activity is described as the first-order constant of the decomposition of H~2~O~2~ at 25^°^ C/g of wet tissue. k~15~ is the constant kinetic of the first order that describes the decomposition of H~2~O~2~ at room tempreture. The GSH-Px activity is expressed in international units of enzymatic activity/mg of protein. International units are expressed in *μ*  mol of transformed hydroperoxides/min/mL of enzyme. The GST activity is expressed in international units of enzymatic activity/mg of protein.
